Monthly Archives: October 2009
Clouds Over the VC sky
Clouds Over the VC sky by Steven Dickman, CEO, CBT Advisors Last week I attended a one-on-one podium discussion put on by Xconomy featuring two Boston gods of private equity and venture capital, Peter Brooke, founder of TA Associates and … Continue reading
Filed under Uncategorized
Great week for Spiegelmers, other nucleic acid drugs points to brighter future
Great week for Spiegelmers, other nucleic acid drugs points to brighter future by Steven Dickman, CEO, CBT Advisors Spiegelmers, the new drug class consisting of mirror-image aptamers created by Germany’s NOXXON Pharma, achieved an important clinical milestone this week. The … Continue reading
Filed under Uncategorized
Coming soon to a Pharma near you: complex tissue culture models
For those looking for an up-and-coming area of new life sciences investment, I think I found it: tissue culture systems that mimic the body’s responses to drugs or other substances.
I co-chaired and spoke at a fascinating meeting last month in Potsdam, Germany, entitled “Organotypic Tissue Culture for Substance Evaluation” that had a little of everything: single-organ models, multiple-organ models, 3-d models, stem cell-based models, nanotechnology and “organs on a chip.” In addition, we heard that there will be tremendous pressure from regulatory authorities to minimize or eliminate the use of experimental animals in substance testing. The broad conclusion: multiple areas of research and policy are converging, especially in Europe, that will drive technology advancement, product development and rapid adoption of these non-animal tests in multiple industries. Continue reading
Filed under Uncategorized
